title: A tropism-modified adenoviral vector increased the effectiveness of gene therapy for arthritis.
abstract: Adenoviral vectors (AdV) are used for anti-inflammatory cytokine therapy in experimental arthritis. Cell entry of AdV is dependent on the initial recognition of the coxsackie-adenovirus receptor (CAR) on cells. Recently, an Arg-Gly-Asp (RGD) motif was introduced in the HI loop of the fiber knob, this enables the adenovirus to bypass CAR and mediate cell entry via RGD binding integrins. In this study, we explored the transduction efficiency of the RGD-modified adenovirus in synovium and compared the RGD-modified with the conventional adenoviral vector for their effectiveness to modulate the murine collagen-induced arthritis (CIA) model when used to overexpress mIL-1Ra in the knee joint. Twenty-four hours after intra-articular injection of 10(7) fluorescent forming units (ffu) virus, luciferase (luc) activity in Ad5LucRGD-injected joints was up to 38 times higher than in AdCMVLuc-injected joints, and in arthritic joints the transduction efficiency was up to 69 times higher for the Ad5LucRGD viruses. Transduction of the synovial lining by the RGD-modified adenovirus containing the mIL-1Ra transgene, markedly improved the inhibition of CIA compared with the conventional virus in both a prophylactic and therapeutic treatment protocol. These results show that targeting integrins with the RGD-modified AdV improved the outcome of gene therapy for arthritis.
authors.affiliation: University Hospital Nijmegen, Nijmegen, The Netherlands.
authors.forename: A C
authors.initials: AC
authors.lastname: Bakker
authors.forename: F A
authors.initials: FA
authors.lastname: Van de Loo
authors.forename: L A
authors.initials: LA
authors.lastname: Joosten
authors.forename: M B
authors.initials: MB
authors.lastname: Bennink
authors.forename: O J
authors.initials: OJ
authors.lastname: Arntz
authors.forename: I P
authors.initials: IP
authors.lastname: Dmitriev
authors.forename: E A
authors.initials: EA
authors.lastname: Kashentsera
authors.forename: D T
authors.initials: DT
authors.lastname: Curiel
authors.forename: W B
authors.initials: WB
authors.lastname: van den Berg
mesh_terms: D000256:Adenoviridae / Q000235:genetics*; D000818:Animals; D001169:Arthritis, Experimental / Q000378:metabolism / Q000473:pathology / Q000628:therapy*; D015316:Genetic Therapy / Q000379:methods*; D005822:Genetic Vectors / Q000627:therapeutic use*; D053590:Interleukin 1 Receptor Antagonist Protein; D008297:Male; D051379:Mice; D008810:Mice, Inbred C57BL; D008811:Mice, Inbred DBA; D009842:Oligopeptides / Q000235:genetics; D011971:Receptors, Immunologic / Q000235:genetics; D020133:Reverse Transcriptase Polymerase Chain Reaction; D012795:Sialoglycoproteins / Q000096:biosynthesis / Q000235:genetics*; D013583:Synovial Membrane / Q000378:metabolism; D014161:Transduction, Genetic; D018523:Tropism
chemical_list: C507764:Il1rn protein, mouse; D053590:Interleukin 1 Receptor Antagonist Protein; D009842:Oligopeptides; D011971:Receptors, Immunologic; D012795:Sialoglycoproteins; C047981:arginyl-glycyl-aspartic acid